Vaginal Mesh Lawsuit Update [September 2026 Guide]

A federal jury in Boston ordered Medtronic to pay $88 million in the first bellwether trial out of more than 10,350 pending Covidien hernia mesh cases nationwide.

Jurors found Covidien liable for failing to warn about risks tied to its Symbotex hernia mesh and for concealing product information.

The award included $77 million to the plaintiff and $11 million to his wife for loss of consortium.

The plaintiff alleged the mesh’s protective coating dissolved in about seven days, far sooner than intended, causing it to adhere to his bowel and require additional surgeries.

Medtronic said it plans to challenge the verdict in post-trial motions and on appeal.

The verdict is expected to shape settlement talks across the remaining cases as more bellwether trials proceed.

The case described above is related to Covidien hernia mesh litigation, which is a separate and distinct legal action apart from active vaginal and pelvic mesh cases.

A new lawsuit has been filed against Boston Scientific in California Superior Court, alleging its Lynx Suprapubic Mid-Urethral Sling System eroded into the plaintiff’s bladder.

The suit alleges that the plaintiff was first implanted with the Lynx mesh in April 2024, claiming Boston Scientific knew of shrinkage and contraction risks since 2011 warnings but failed to adequately disclose them.

The plaintiff required multiple corrective surgeries starting in August 2024 after the mesh disintegrated and triggered a hyperinflammatory response.

The suit alleges design defect, manufacturing defect, and failure to warn, seeking compensatory and punitive damages.

The case joins more than 100,000 transvaginal mesh lawsuits filed against Boston Scientific and other manufacturers, following a 2019 FDA order pulling all transvaginal mesh products from the market after finding the risks outweighed the benefits.

New Jersey courts continue to move the remaining transvaginal mesh lawsuits forward years after the federal multidistrict litigations (MDLs) concluded, with new case management orders extending discovery and advancing pretrial proceedings in the state’s multicounty litigation (MCL).

The New Jersey Superior Court recently issued updated case management orders for the Bard and Ethicon pelvic mesh litigations, extending discovery deadlines into 2026 and establishing schedules for expert discovery, dispositive motions, and additional pretrial proceedings.

The court also continues to activate new cases while dismissing others without prejudice, leaving hundreds of transvaginal mesh lawsuits pending in the state’s coordinated litigation.

The latest Ethicon case management order reports more than 560 active cases remaining in the multicounty litigation, while Bard cases continue under a separate MCL.

The continued activity in New Jersey demonstrates that transvaginal mesh litigation remains active even after the federal MDLs closed.

Plaintiffs with unresolved claims continue through state court proceedings, where coordinated discovery and pretrial management help streamline litigation involving similar allegations against pelvic mesh manufacturers.

The New Jersey Bard pelvic mesh litigation continues to generate routine case management activity as individual lawsuits move through the multicounty litigation.

In one recent filing, the court granted an unopposed motion allowing counsel to withdraw from representation in an individual Bard transvaginal mesh lawsuit while directing that notices continue to be provided until replacement counsel appears.

Procedural orders like these demonstrate that individual transvaginal mesh lawsuits remain active in New Jersey state court as judges continue to manage case-specific issues alongside broader discovery and pretrial proceedings.

A recent study published in Applied Sciences evaluates biodegradable mesh implants as a potential alternative to polypropylene devices at the center of Transvaginal Mesh Lawsuits.

The research uses computational modeling to analyze pelvic organ prolapse (POP) repair and assess whether newer materials may reduce complications linked to earlier mesh products.

The study follows regulatory action by the U.S. Food and Drug Administration (FDA), which banned transvaginal mesh devices for anterior compartment prolapse repair in 2019 after reports of erosion, chronic pelvic pain, and dyspareunia.

Transvaginal Mesh Lawsuits allege that permanent polypropylene implants caused long-term injuries that often required revision surgeries.

Researchers developed biodegradable implants using polycaprolactone (PCL), a material designed to provide temporary support and gradually degrade.

The study simulated ligament damage within the pelvic floor and measured displacement of the anterior vaginal wall to evaluate implant performance.

Results showed that complete uterosacral ligament rupture increased displacement by 69%, while cardinal ligament rupture increased displacement by 34%, confirming the greater structural role of the uterosacral ligaments in pelvic support.

The biodegradable implants reduced displacement across multiple impairment scenarios, with square-shaped designs providing higher stiffness and stronger support in severe cases, while sinusoidal designs allowed greater flexibility and improved load distribution in partial ligament damage.

The study also found that fixation methods influenced outcomes, with continuous and interrupted sutures providing more stable support than simple stitch techniques.

State courts handling remaining transvaginal mesh lawsuits are increasingly requiring strict compliance with Plaintiff Fact Sheets (PFS), making them a key factor in whether cases can move forward.

A Plaintiff Fact Sheet is a detailed form that each plaintiff must submit under oath.

It includes core case information such as medical records, details about the mesh implant and any revision surgeries, the doctors involved, and a timeline of injuries.

Courts treat these forms like formal discovery responses, meaning they must be complete, accurate, and supported by documentation.

Judges are now closely reviewing whether plaintiffs meet these requirements.

If a Fact Sheet is missing information or lacks proper records, defendants are filing motions to dismiss the case or force compliance within a set deadline.

In response, courts are issuing orders requiring plaintiffs to address any issues within a specific timeframe.

If they fail to do so, judges are increasingly dismissing cases, sometimes permanently, meaning the claim cannot be refiled.

This has made compliance with Plaintiff Fact Sheet requirements a gatekeeping issue in the current phase of the litigation.

As the earlier federal proceedings have largely concluded, these state court requirements now determine which transvaginal mesh cases proceed to expert review and trial and which are dismissed before reaching that stage.

This is based on case management orders issued in the federal transvaginal mesh MDLs in the Southern District of West Virginia, where courts required Plaintiff Fact Sheets as sworn discovery and dismissed cases for noncompliance.

A recent case in Wales is drawing renewed attention to ongoing legal claims involving vaginal mesh implants in the United Kingdom, particularly allegations that patients were not properly warned about the risks before surgery.

A woman from Conwy, Wales, says she has lived with chronic pain since receiving a vaginal mesh implant in 2014 to treat a prolapsed bladder.

She now reportedly takes more than 100 pain tablets each week and relies on a walking stick due to the complications.

Vaginal mesh implants, which are used to treat pelvic organ prolapse and urinary incontinence, have been linked to complications including severe pelvic pain, infections, and urinary problems in some patients.

Safety concerns ultimately led the NHS to pause the use of vaginal mesh implants in 2018.

Health officials in Wales have also acknowledged that record keeping and consent procedures were not completed to the required standard in some historical cases, an issue that continues to play a central role in legal claims brought by women injured by the devices.

In the United States, vaginal mesh claims are still being filed in state courts across the country after federal multidistrict litigations were settled throughout the 2010s.

Transvaginal mesh lawsuits involve product liability claims alleging that surgical mesh implants used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) caused severe injuries without adequate warnings.

Plaintiffs assert that manufacturers failed to disclose known risks and that design defects made the devices unreasonably dangerous.

Plaintiffs in transvaginal mesh lawsuits claim:

• Mesh erosion through vaginal tissue, leading to pain, bleeding, infection, and organ perforation.
• Mesh contraction, scarring, and chronic discomfort affecting sexual function and quality of life.
• Inadequate instructions, warnings, and risk communication to surgeons and patients.
• Defective product design and insufficient testing before widespread clinical use.

Allegations focus on long-term complications and the persistence of symptoms after mesh removal surgery.

Plaintiffs argue that manufacturers knew or should have known of the high failure rates and severity of complications based on adverse event reports and clinical evidence.

Federal transvaginal mesh lawsuits against multiple major medical device companies were centralized into multidistrict litigations to streamline pretrial processes.

The Judicial Panel on Multidistrict Litigation (JPML) consolidated cases from across the country into MDLs.

MDL status facilitates coordinated discovery, expert designation, and pretrial motions. Centralization does not resolve individual cases but aims to reduce duplicative litigation efforts.

Bellwether trials were conducted to assess liability issues, causation evidence, and potential compensation ranges.

Some early bellwether verdicts returned verdicts for plaintiffs, while others favored defendants, reflecting the complexity of mesh-related injuries and evidence.

In addition to federal MDLs, several state court coordinated proceedings and settlements addressed similar claims.

Transvaginal mesh lawsuits typically involve product liability theories, including:

• Failure to warn: Claims that labels and surgeon guides did not sufficiently warn of known risks.
• Defective design: Claims that mesh products were unreasonably dangerous by design.
• Negligence and breach of warranty under state law.

Some manufacturers issued recalls or changes to product labeling.

Settlements in federal and state actions resolved large numbers of claims, often through trust funds or structured settlement frameworks.

Now, MDL cases for vaginal mesh injuries are closed and settled. 

Cases are still being filed in state courts across the country and women who’ve suffered injuries are able to pursue legal action. 

TorHoerman Law is reviewing transvaginal mesh claims from women across the country. 

Reach out today for a free consultation or use the chat feature on this page to find out if you qualify for a vaginal mesh claim.

New Jersey’s coordinated pelvic mesh litigation is placing increased emphasis on Plaintiff Fact Sheet compliance as a gatekeeping issue that determines whether cases remain active.

Recent case management orders clarify submission deadlines, required medical records, and supporting documentation needed to move claims forward.

The court has reinforced that Plaintiff Fact Sheets are not informal disclosures.

They function as sworn discovery responses and must be complete and timely.

When plaintiffs miss deadlines or submit incomplete materials, defendants are increasingly seeking enforcement, including dismissal motions, sanctions, or court-ordered cure periods.

These enforcement disputes are becoming a key pressure point in the docket.

Courts are signaling that continued noncompliance may result in cases being dismissed with prejudice, while compliant plaintiffs are positioned to proceed into expert discovery and trial scheduling.

Transvaginal mesh lawsuits increasingly turn on disputes over when the statute of limitations begins to run for women who undergo mesh removal or revision surgery years after implantation.

Recent filings argue that complications tied to mesh erosion, chronic pain, or organ damage often worsen gradually, delaying diagnosis and surgical intervention.

Plaintiffs allege manufacturers such as Ethicon and Boston Scientific failed to warn that transvaginal mesh complications could require multiple surgeries over time.

As a result, patients often did not connect ongoing symptoms to the mesh device until explant surgery confirmed mesh-related injury.

This issue matters because defendants frequently seek dismissal by arguing claims are time-barred based on the original implantation date.

Courts reviewing transvaginal mesh lawsuits are examining whether explant surgery, worsening symptoms, or definitive medical confirmation triggers the limitations period rather than the initial procedure.

Attorneys representing injured patients continue to rely on operative reports, pathology findings, and post-explant medical records to establish delayed discovery of mesh-related harm.

How courts resolve explant-based statute of limitations arguments remains a narrow but decisive issue in surviving dismissal motions across remaining transvaginal mesh litigation.

A new lawsuit filed in the District of Massachusetts alleges that Boston Scientific’s Obtryx II mid-urethral sling continues to cause serious injuries years after its implantation.

Yvonne Cummings reports that she received the device in 2016 and underwent mesh excision surgery on November 4 after developing erosion, chronic pelvic pain, inflammation, dyspareunia, and vaginal bleeding.

Her complaint suggests she might require further procedures and anticipates ongoing pain and permanent complications. Her husband files a claim for loss of consortium.

The filing highlights the same safety concerns that caused the FDA to remove all transvaginal mesh from the market in 2019.

The agency’s decision partly depended on Boston Scientific’s postmarketing studies, which indicated minimal clinical benefit over native tissue repair.

Although most transvaginal mesh litigation has been settled, individual cases like Cummings’ continue to advance in state and federal courts.

A woman from Tolono has filed a new lawsuit in the U.S. District Court for the Central District of Illinois, alleging she suffered serious injuries from the Sparc Sling System, a pelvic mesh device manufactured by American Medical Systems and Endo Pharmaceuticals.

The plaintiff states she received the implant in July 2020 and later required corrective surgery in January 2024 after experiencing mesh erosion and other complications.

The complaint alleges that the defendants are responsible for negligence, strict liability for design and manufacturing defects, failure to warn, and fraudulent concealment.

It claims that the Sparc Sling’s polypropylene and collagen materials are biologically incompatible with human tissue, causing chronic inflammation, pain, and other injuries.

According to the filing, the companies failed to disclose known safety risks and continued marketing the product as safe and effective despite regulatory concerns.

The lawsuit cites the FDA’s 2011 Safety Communication warning about serious risks associated with transvaginal mesh implants.

Emerging research and litigation trends now highlight distinct differences between mesh implants used for Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP).

Complication Rates & Device Design

• POP Mesh (transvaginally placed for prolapse) presents significantly higher complication rates: studies report overall mesh-related issues in 27–40% of cases, with reoperation rates reaching 8–13% within the first year post-surgery.
• Serious complications like tissue erosion, infection, and pain requiring surgery are especially common in POP cases.

Regulatory Actions

• The FDA issued public health warnings in 2008–2011 for both SUI and POP mesh, but took decisive regulatory action only in 2019—when it reclassified POP mesh as a Class III “high-risk” device and effectively banned its transvaginal use.
• SUI slings remain on the market, classified as moderate-risk Class II

Lawsuit Volume & Patterns

• Over 73,000 transvaginal mesh lawsuits filed between 2000 and 2014 involved both POP and SUI products.
• Though SUI slings accounted for approximately 60% of cases filed, POP mesh cases often result in higher awards due to severe harm patterns.
• POP mesh lawsuits peaked following FDA safety communications. Manufacturers recalled POP products before mandatory premarket approval processes began .

Aoife Ní Eochaidh, a Chartered Physiotherapist based in West Clare, Ireland, is urging the Irish government to implement a full ban on transvaginal mesh (TVM) implants.

The call was made during a recent delegation briefing at Leinster House, where Ní Eochaidh warned of the long-term health risks associated with the devices, including chronic pelvic pain and irreversible complications.

TVM implants, commonly used to treat pelvic organ prolapse and stress urinary incontinence, have been the subject of international scrutiny due to reports of serious adverse outcomes.

Ní Eochaidh emphasized that unless immediate action is taken, more women in Ireland are likely to suffer the same complications reported in other countries.

The appeal adds to a growing international movement to restrict or ban TVM devices.

Regulatory agencies in the United States, United Kingdom, and Australia have already taken action, including product withdrawals and usage suspensions, in response to thousands of patient complaints and lawsuits.

The Irish government has not yet responded to the most recent call for a ban.

However, the renewed attention may prompt further policy review as medical experts and advocacy groups continue to raise concerns over mesh safety.

Litigation surrounding pelvic mesh implants remains active as patients continue to report serious complications tied to Transvaginal Mesh (TVM) devices.

A recent report published by Drugwatch highlights the experience of Donna Miser, a woman who suffered extensive physical and emotional harm years after receiving a pelvic mesh implant for urinary incontinence.

Miser experienced chronic pelvic pain, bloody discharge, and debilitating pain during intercourse.

Her symptoms were initially dismissed by multiple providers until a specialist discovered that the mesh had eroded into her urethra, bladder, and vaginal wall.

She has since undergone multiple removal surgeries and continues to suffer long-term complications.

The FDA banned the sale of TVM for pelvic organ prolapse in 2019 but allowed the continued use of mesh slings for stress urinary incontinence.

Despite the regulatory changes, many women implanted prior to the ban continue to report erosion, chronic pain, infection, nerve damage, and sexual dysfunction.

More than 100,000 pelvic mesh lawsuits have been filed against manufacturers such as Ethicon (Johnson & Johnson), Boston Scientific, and C.R. Bard.

Settlements across the industry have reached into the billions, with some individual verdicts totaling millions of dollars.

While most federal cases were consolidated into multidistrict litigation (MDL), individual claims continue to emerge as patients become aware of the link between their injuries and the implanted devices.

Donna Miser’s story is one of many that may fuel additional claims and draw renewed attention to the long-term risks associated with pelvic mesh implants.

Plaintiffs allege that manufacturers failed to adequately warn of the potential for erosion, chronic pain, and permanent injury.

Midurethral mesh slings, widely used to treat stress urinary incontinence, have become the center of numerous lawsuits due to severe complications reported by patients.

Issues such as chronic pain, infections, mesh exposure, and organ perforations have raised questions about the safety and design of these devices.

Recent scientific research is shedding light on why these complications occur.

A study published in Applied and Environmental Microbiology in June 2025 reveals that bacterial colonization on midurethral mesh slings may contribute to many of the complications experienced by patients.

The research shows that bacteria growing on the mesh are distinct from those found in the surrounding vaginal, urinary, or skin environments.

Additionally, meshes from patients experiencing chronic pain showed higher bacterial diversity, with certain bacteria like Enterococcus being prevalent.

These findings suggest a link between bacterial presence on the mesh and inflammatory complications.

Patients affected by midurethral mesh slings have filed lawsuits alleging that manufacturers were negligent in their duty to ensure the safety of these devices.

Common claims include defective design, which allegedly encourages harmful bacterial growth; failure to warn about potential risks; and insufficient premarket testing to reveal the long-term issues associated with bacterial colonization and chronic complications.

These lawsuits seek compensation for medical expenses, lost income, pain and suffering, and other damages.

A new study published in Nature Reviews Urology has found that microscopic particles from transvaginal mesh (TVM) implants may trigger autoimmune responses, even after the mesh has been surgically removed.

The findings may have implications for ongoing and future TVM litigation.

The research, led by Dr. Nicholas Farr, identifies polypropylene particles — the material commonly used in mesh devices — as potential contributors to Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA).

The study suggests that even after mesh removal, these particles can persist in surrounding tissue and continue to provoke an immune reaction.

These findings directly challenge earlier research, including a 2017 study in the American Journal of Obstetrics and Gynecology, which concluded there was no link between mesh implants and autoimmune or systemic diseases.

The FDA is proposing to label transvaginal mesh for pelvic organ prolapse (POP) as a high-risk device.

If the change is finalized, mesh makers must submit complete safety and effectiveness data before selling these products.

The agency also wants to reclassify the tools used to insert and anchor the mesh, bumping them from low- to moderate-risk.

These updates follow years of reports linking the mesh to serious complications.

The FDA first raised concerns in 2008 and followed up with warnings and review orders in 2011 and 2012.

The proposed orders are open for public comment for 90 days.

Mesh used for hernias, stress urinary incontinence, or abdominal POP repair isn’t affected.

Transvaginal mesh implants were introduced in the late 1990s to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

These implants aimed to provide support to pelvic tissues but have been associated with serious complications, including chronic pain, organ perforation, bleeding, and mesh erosion.

These adverse effects have led to numerous lawsuits against manufacturers.

Resolution of Multidistrict Litigations (MDLs)

Over the years, thousands of lawsuits were consolidated into MDLs to streamline the legal process.

In November 2022, the final MDL overseeing federal Transvaginal Mesh Lawsuits concluded, with many cases resolved through settlements.

However, this resolution does not preclude individuals from pursuing their own claims.

Women who have suffered injuries due to transvaginal mesh implants retain the right to file individual lawsuits, seeking compensation tailored to their specific circumstances.​

Filing Individual Claims

Filing an individual claim allows plaintiffs to present the unique aspects of their cases, which can be crucial for cases with distinct facts or severe injuries.

Individual lawsuits may offer several advantages:​

• Personalized Representation: Each case can be evaluated on its specific facts, potentially leading to more favorable outcomes.​
• Potential for Higher Settlements: Individual claims may result in higher compensation, as they are not subject to the broader averages that can occur in MDLs. ​
• Control Over Legal Strategy: Plaintiffs have more influence over legal decisions, including settlement negotiations and trial considerations.​

Current Legal Landscape

As of early 2025, several manufacturers have agreed to substantial settlements.

For instance, Johnson & Johnson reached a settlement of $120 million in January 2016 to resolve approximately 3,000 cases.

However, many cases remain unresolved, and ongoing litigation continues in both state and federal courts.

Recent Developments

In August 2024, 140 women in England received compensation after experiencing complications from vaginal mesh implants.

The settlement involved manufacturers such as Johnson & Johnson, Bard, and Boston Scientific, and addressed issues like chronic pain and organ perforations.

Considerations for Potential Plaintiffs

Women considering legal action should be aware of several factors:

• Statute of Limitations: Time limits for filing claims vary by jurisdiction. It’s essential to consult legal counsel promptly to ensure adherence to applicable deadlines.​
• Evidence of Injury: Documenting the connection between the mesh implant and the resulting health issues is crucial for a successful claim.​
• Legal Representation: Engaging attorneys experienced in transvaginal mesh litigation can provide valuable guidance through the legal process.

Over 100,000 Transvaginal Mesh Lawsuits have been filed across courts in the United States on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

A University of Sheffield study has revealed critical shortcomings in polypropylene (PP) used in transvaginal mesh (TVM) implants.

Researchers found that the material begins to degrade within 60 days of implantation, with further deterioration observed by 180 days.

The degradation, marked by oxidation and the accumulation of PP debris in surrounding tissues, contradicts previous assumptions about its chemical inertness.

This degradation contributes to a mismatch between the PP fibers and surrounding tissues, causing inflammation, tissue damage, and persistent pain.

These findings underscore the need to reassess the biocompatibility of PP mesh implants, which have been linked to side effects such as pelvic pain, infection, and difficulty urinating.

The NHS restricted the use of TVM implants in 2018, now allowing them only under a high-vigilance framework.

This study adds to the growing body of evidence supporting lawsuits filed by women who have experienced debilitating complications.

Recent settlements have been reached for over 100 claims in England.

Campaigners are urging immediate action to develop safer alternatives.

Over 100,000 Transvaginal Mesh Lawsuits have been filed across courts in the United States on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

A new study has found that polypropylene, the material commonly used in transvaginal mesh (TVM) implants, starts to degrade within 60 days of implantation in the pelvis.

This discovery adds to growing concerns over the safety of TVM implants, which have been used to treat pelvic organ prolapse and stress urinary incontinence but are linked to severe side effects, including pelvic pain, infection, and difficulty urinating.

The study, conducted by researchers at the University of Sheffield in the United Kingdom, examined the degradation of polypropylene mesh in sheep, which share similar pelvic anatomy to humans.

The research revealed that the material becomes stiffer and shows signs of oxidation over time. Additionally, polypropylene particles were discovered in the tissue surrounding the implant site, with concentrations increasing over time.

Campaigners are calling for immediate action from medical authorities to prevent further harm from these implants. 

The findings highlight the need for safer materials and raise concerns that the mesh was not sufficiently tested for use in the pelvis before being widely implemented.

Sheila MacNeil, an emeritus professor of biomaterials and tissue engineering, emphasized the importance of developing new materials to prevent harm to patients.

These results come after more than 100 women in England, who suffered complications from vaginal mesh implants, received compensation in a group settlement.

Dr. Nicholas Farr, the study’s lead researcher, hopes the findings will prompt manufacturers to improve the safety of future implants.

Kath Sansom, founder of the support group Sling The Mesh, pointed to the study as further evidence of the dangers associated with polypropylene mesh.

She urged immediate changes in medical practice and called for alternative methods to be used to treat pelvic organ prolapse and incontinence.

Over 100,000 Transvaginal Mesh Lawsuits have been filed across courts in the United States on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

The Hernia Mesh Lawsuit MDL has seen a huge update and a large step towards compensation for victims.

Bard has agreed to settle nearly all cases in the hernia mesh multidistrict litigation (MDL) and Rhode Island state court.

This settlement resolved over 30,000 claims, marking the end of a hard-fought legal battle.

The Bard Hernia Mesh MDL, which began in August 2018, faced delays due to COVID-19 and a series of trials in both MDL and RI state court.

After the MDL judge adjourned a scheduled bellwether trial in early 2024 and ordered mediation, a settlement seemed likely.

Now, after months of negotiations, an agreement has been reached to provide compensation for clients who suffered from defective Bard hernia mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

The United States Court of Appeals for the Eleventh Circuit has upheld the lower court’s decision in the case of Virginia Redding vs. Coloplast Corporation.

This appeal addressed the statute of limitations for vaginal mesh product liability claims under Florida law.

Virginia Redding filed a lawsuit against Coloplast Corporation on September 18, 2014, alleging that the vaginal mesh devices implanted in her body were defectively designed, resulting in serious harm.

Coloplast argued that Redding’s lawsuit was time-barred under Florida’s four-year statute of limitations for product liability claims, as her symptoms began more than four years before she filed suit.

The court found no error in the district court’s decision, affirming that Redding did not know, and should not have known, of a distinct injury caused by the mesh before September 18, 2010.

The jury awarded Redding $2.5 million in damages, and the district court denied Coloplast’s renewed motion for judgment as a matter of law.

The case highlights the complexities surrounding product liability lawsuits, particularly regarding the statute of limitations.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

A Philadelphia jury awarded $20 million in damages to a woman from Cinnaminson, NJ, who suffered injuries related to a vaginal mesh product manufactured by Ethicon, a subsidiary of Johnson & Johnson.

The lawsuit, filed in the Philadelphia Common Pleas Court, concluded in late April.

The jury found that the surgical mesh device did not perform as advertised and caused the woman chronic pain and multiple revision surgeries.

The three-week trial focused on Ethicon’s TVT-Secur transvaginal mesh product used to treat pelvic organ prolapse and stress urinary incontinence.

The woman underwent a procedure for stress urinary incontinence with the TVT-Secur mesh, which began eroding within two months.

Despite three surgeries to remove the mesh, fragments remain in her body, causing ongoing pain and urinary dysfunction.

She claimed that Johnson & Johnson failed to provide adequate warnings about the risks and did not supply sufficient instructions.

The jury awarded $2.5 million for economic and non-economic damages, including medical bills.

An additional $17.5 million was awarded in punitive damages, indicating the jury’s view of Ethicon’s conduct as egregiously negligent.

This $20 million verdict is one of several significant awards against Ethicon and Johnson & Johnson concerning mesh devices that pose increased risks of injuries and complications.

Despite recalls of the TVT-Secur and other mesh products, many patients who underwent procedures using these devices continue to suffer complications.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

The FDA has completed its evaluation of the final reports for the 522 SUI Mini-Slings studies, which show that SUI mini-slings are as effective as traditional mid-urethral slings over a 36-month period.

The studies also revealed similar types and rates of adverse events and re-surgery for both SUI mini-slings and traditional mid-urethral slings. .

The FDA also performed a systematic literature review of 30 randomized controlled clinical trials published between 2013 and 2023.

This review compared the safety and effectiveness of SUI mini-slings with traditional mid-urethral slings, supporting the conclusion that SUI mini-slings perform comparably to traditional mid-urethral slings.

Surgical mesh sling procedures are commonly used to correct stress urinary incontinence (SUI).

The FDA required manufacturers of surgical mesh used for SUI, specifically mini-slings, to conduct long-term follow-up studies to evaluate their safety and effectiveness.

The results from these studies, along with the systematic literature review, indicate that mini-slings are as effective and safe as traditional mid-urethral slings.

The FDA will continue monitoring and evaluating these devices to ensure their safety and effectiveness for treating stress urinary incontinence.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

Despite the widely known risks and thousands of lawsuits against vaginal mesh manufacturers, women are still dealing with severe side effects from these procedures.

Vaginal mesh implants, often used to treat urinary incontinence and pelvic organ prolapse, continue to cause significant complications for many women worldwide.

Many women report chronic pain, erosion of the mesh into surrounding tissues, and severe incontinence following vaginal mesh surgeries.

These complications often lead to multiple revision surgeries and a lifetime of discomfort and medical issues.

The difficulty in removing the mesh once implanted exacerbates these problems, leaving many women with incomplete relief even after additional procedures.

The widespread issues with vaginal mesh have led to numerous lawsuits and significant settlements.

Healthcare providers and manufacturers face increasing scrutiny over the use of these implants.

Many women have successfully pursued legal claims, highlighting the importance of informed consent and the exploration of less invasive treatment options before resorting to surgery.

Despite this, many patients still find themselves struggling with debilitating symptoms and a reduced quality of life.

The severe side effects of vaginal mesh implants have far-reaching impacts on the lives of affected women.

Chronic pain, incontinence, and the emotional toll of these conditions significantly reduce their ability to engage in daily activities and maintain an active lifestyle.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

A recent £1 million settlement in the United Kingdom highlights the severe complications and negative impacts of avoidable vaginal mesh surgeries.

A woman received the settlement after experiencing chronic pain and ongoing health issues due to a mesh implant.

Vaginal mesh implants, often used to treat urinary incontinence and pelvic organ prolapse, have been linked to significant health risks.

Patients have reported chronic pain, mesh erosion, and recurring symptoms.

In some cases, surgeries were performed prematurely or without exhausting other treatment options, leading to unnecessary complications.

Patients affected by avoidable vaginal mesh surgeries may be entitled to compensation for their suffering and ongoing medical needs.

Legal actions have resulted in substantial settlements, highlighting the importance of thorough patient consent and careful consideration before surgery.

If you have experienced negative effects from a vaginal mesh implant, you may be eligible for compensation to cover medical expenses, ongoing care, and other related costs.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

A recent study highlights the advantages of Polyvinylidene Fluoride (PVDF) meshes over traditional polypropylene meshes for vaginal mesh procedures.

Published in Diagnostics 2023, the study shows that PVDF meshes offer better biostability, less inflammation, and reduced scarring, which lowers the incidence of chronic pain.

In a three-year follow-up of women treated for anterior/apical vaginal prolapse with PVDF meshes, 85.2% achieved anatomic success, with minimal complications such as mesh protrusion or pain.

Despite these benefits, PVDF meshes are not widely used in the United States due to higher costs.

Dr. Greg Vigna, an expert in mid-urethral sling complications, criticizes the continued use of polypropylene meshes in the U.S., advocating for the safer PVDF option.

His law group investigates complications from mid-urethral slings and represents affected women nationwide.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

Women all over the world are being misinformed before surgery involving transvaginal mesh implants, and many are left with painful and life changing complications.

The Transvaginal Mesh Case Record Review found that many women were not accurately informed about the surgery or its risks.

The review examined over 40,000 pages of records from 18 women, revealing that poor communication and misleading information left many unprepared for chronic pain and nerve damage.

The lack of clear, accurate information from doctors led to mistrust and inadequate aftercare.

The review called for a comprehensive register to track mesh implant surgeries and removals.

It emphasized the need for better aftercare, clear communication, and accurate medical records to support affected women.

Misinformation about transvaginal mesh implants has caused significant harm. Legal actions and reviews aim to improve healthcare practices.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.

Vaginal mesh implants, originally intended to treat incontinence and prolapse post-childbirth, have led to numerous adverse effects, causing a surge in vaginal mesh lawsuits.

Thousands of women received transvaginal mesh implants in Scotland before the procedure was halted in 2018.

These implants have caused life-altering side effects, including chronic pain, autoimmune issues, and severe fatigue.

Many women have had to undergo private treatments to alleviate their symptoms, further exacerbating their distress and financial burden.

The Complex Mesh Surgical Service (CMSS) was established to support women affected by transvaginal mesh.

However, feedback from many women highlighted significant shortcomings in the service, including unclear referral pathways and long wait times for appointments.

Women reported educating their GPs about mesh complications, reflecting a lack of knowledge among healthcare providers.

Numerous women have experienced severe injuries from mesh implants, forcing them to abandon their careers.

Despite undergoing surgeries locally, many have had to travel abroad for more comprehensive removal procedures.

Women suffering from complications due to transvaginal mesh implants are seeking justice through vaginal mesh lawsuits,

Improved healthcare practices and specialized treatments are essential to address these severe complications.

If you or someone you know is affected, contact a Vaginal Mesh lawsuit lawyer to explore your legal options and secure the compensation you deserve.

A 57-year-old Canadian woman has filed a lawsuit against Johnson & Johnson, alleging significant health issues caused by a surgical mesh product manufactured by Ethicon, a subsidiary of Johnson & Johnson.

The lawsuit claims the mesh, implanted after a partial hysterectomy in 2008, led to severe complications including chronic pain and organ damage.

Over a decade following the surgery, the plaintiff experienced escalating pain that affected her ability to work and maintain social relationships.

Medical investigations revealed in 2021 that the mesh had fragmented and embedded in her organs, causing serious infections and necessitating multiple surgeries, including emergency procedures to prevent septic risk.

Johnson & Johnson has defended the safety and effectiveness of its pelvic mesh products, attributing their market withdrawal to commercial reasons rather than safety concerns.

This stance comes despite numerous global reports and legal actions that suggest a different narrative concerning the safety of these products.

Ethicon has previously withdrawn several mesh products from the market, including those used for pelvic organ problems and hernia repairs, following reports of higher than expected failure rates and subsequent surgeries.

These withdrawals have fueled ongoing legal challenges and public scrutiny.

The lawsuit in Winnipeg adds to the growing body of global litigation related to surgical mesh products.

In Scotland, for example, the government has taken steps to support women suffering from complications due to transvaginal mesh implants, including funding for mesh removal surgeries.

The vaginal mesh lawsuit focuses on severe complications arising from transvaginal mesh implants.

These medical devices, designed to treat pelvic organ prolapse and stress urinary incontinence, are now at the center of legal scrutiny due to their failure and resultant severe health consequences.

Plaintiffs allege that the mesh implants have led to painful complications such as mesh erosion, infection, organ perforation, and pain during intercourse.

These conditions often require additional corrective surgeries and can lead to chronic pain and disability.

Major manufacturers involved in this lawsuit include Ethicon, a subsidiary of Johnson & Johnson, along with C.R. Bard, American Medical Systems, and others.

These companies are accused of failing to adequately test the devices and of not informing patients and physicians of known, potentially severe risks.

As of the latest updates, numerous cases have been settled, while others proceed through various stages of litigation.

Some manufacturers have ceased production of certain mesh products in response to the mounting evidence and legal actions.

Over 100,000 Transvaginal Mesh Lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products.

If you or a loved one have suffered serious complications or injuries from vaginal mesh, you may be eligible to file a Vaginal Mesh Lawsuit.

Contact an experienced Transvaginal Mesh Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Vaginal Mesh Lawsuit instantly.